Biological Products, (No Diagnostic Substances) · WA · CIK 1478320
They decode the adaptive immune system to transform disease diagnosis and treatment
Comparable business profile · signals at a glance
In the 90 days to Mar 31, 2026: 8 sold $39.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.45 | $256K |
| Mar 30, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $12.63 | $241K |
| Mar 27, 2026 | Rubinstein JuliePresident and COO | Sell | 16,322 | $13.48 | $220K |
| Mar 27, 2026 | Rubinstein JuliePresident and COO | Sell | 2,738 | $12.49 | $34K |
| Mar 26, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $14.12 | $269K |
| Mar 25, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $14.27 | $272K |
| Mar 24, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.70 | $261K |
| Mar 23, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.83 | $264K |
| Mar 20, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.37 | $255K |
| Mar 19, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.18 | $251K |
| Mar 18, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.18 | $251K |
| Mar 17, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.40 | $255K |
| Mar 16, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.41 | $256K |
| Mar 13, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $12.96 | $247K |
| Mar 12, 2026 | Rubinstein JuliePresident and COO | Sell | 13,660 | $12.63 | $173K |
| Mar 12, 2026 | Rubinstein JuliePresident and COO | Sell | 5,400 | $13.43 | $73K |
| Mar 11, 2026 | Robins Harlan SChief Scientific Officer | Sell | 329,600 | $13.17 | $4.3M |
| Mar 11, 2026 | Robins Chad MCEO and Chairman | Sell | 329,600 | $13.17 | $4.3M |
| Mar 11, 2026 | Robins Harlan SChief Scientific Officer | Sell | 140,666 | $13.17 | $1.9M |
| Mar 11, 2026 | Robins Chad MCEO and Chairman | Sell | 140,567 | $13.17 | $1.9M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.